Related Experiment Video
Updated: May 23, 2026

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine
Published on: October 13, 2023
Cancer and quackery
1History of Medicine, Yale University, New Haven, Connecticut, USA. kathryn.irving@yale.edu
This study examines the conflict between biomedicine and alternative cancer therapies, suggesting oncologists may resist patient autonomy due to authority concerns. It proposes a compromise balancing patient choice with potential risks.
Area of Science:
- Medical History
- Oncology
- Bioethics
Background:
- A 2023 article in the Internal Medicine Journal discussed a cancer survivor's "miracle cure."
- This survivor's case occurred over 30 years ago.
- The article by senior oncologists contested the survivor's claims.
Purpose of the Study:
- To explore the historical conflict between biomedicine and alternative therapies.
- To analyze the motivations behind oncologists' reactions to alternative cancer treatments.
- To propose a resolution for the tension between medical authority and patient choice.
Main Methods:
- Historical analysis of medical literature and practices.
- Examination of the specific case published in the Internal Medicine Journal.
- Exploration of the ethical dimensions of patient autonomy versus medical paternalism.
Main Results:
- The oncologists' critique of the cancer survivor's case may stem from a perceived threat to their professional authority.
- Historical precedents reveal ongoing tension between established medical practice and alternative healing methods.
- Patient autonomy in treatment decisions remains a complex ethical issue in oncology.
Conclusions:
- The conflict highlights a need to address oncologists' potential discomfort with shared decision-making.
- A proposed compromise seeks to respect patient autonomy while acknowledging potential adverse outcomes.
- Reconciling biomedical authority with patient-centered care requires ongoing dialogue and ethical consideration.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11:28Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
Related Concept Videos
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...